Effects of glycopyrrolate on cardiorespiratory function in horses anesthetized with halothane and xylazine.

The research article presents a study on the cardiopulmonary effects of glycopyrrolate in horses anesthetized with halothane and xylazine. The findings suggest that while glycopyrrolate can improve hemodynamic function, it may also result in prolonged intestinal issues, which could limit its use during anesthesia.

Research Purpose and Methodology

• The researchers aimed to evaluate the cardiopulmonary effects of a drug called glycopyrrolate on horses anesthetized using two other substances, halothane and xylazine.
• A total of six horses were studied, each assigned to one of two treatment groups using a randomized complete block design.
• All horses were mechanically ventilated; anesthesia was maintained with 1% halothane and a constant infusion of xylazine hydrochloride.
• Variables relating to heart function were monitored for two hours after the injection of glycopyrrolate or saline solution.
• Glycopyrrolate was administered in intervals until the heart rate rose to be at least 30% higher than the baseline, or until a maximum cumulative dose had been injected.

Results

• The researchers found that the use of glycopyrrolate had a strong positive effect on the heart rate of horses, leading to a substantial increase in both the cardiac output and arterial blood pressure.
• While the horse’s heart rate increased significantly (by 53% over the baseline), the cardiac output increased by 38%, and the mean arterial pressure by 31%.
• However, one undesired side effect was found: the use of glycopyrrolate was related to a case of large colon impaction in one horse and low intestinal auscultation scores that lasted for a day in three horses. This indicates that there may be potential intestinal issues related to the use of this drug.

Conclusions

• The positive chronotropic effects of glycopyrrolate resulted in improvement of hemodynamic function in horses anesthetized with halothane and xylazine.
• However, the researchers observed that glycopyrrolate administration might be linked with prolonged intestinal stasis and colic, which could limit its use during anesthesia procedures in equine practice.